<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Concord Drugs Ltd has submitted an initial disclosure to BSE clarifying that the company does not fall under the category of a "Large Corporate" as per SEBI's framework for fund raising through issuance of debt securities. This determination is based on the applicability criteria specified in SEBI circulars dated November 26, 2018 and October 19, 2023. As of March 31, 2026, the company does not meet the Large Corporate threshold. Consequently, the disclosure and compliance requirements applicable to Large Corporates are not binding on the company.
This filing has no direct impact on shareholders as it merely confirms the company's status below the Large Corporate threshold, meaning no additional debt fundraising disclosure obligations apply. The stock is unlikely to be affected by this routine compliance clarification.